Management of Abnormal Laboratory Values in Indian Clinical Practice

Immediate Risk Stratification and Triage

Patients with marked derangement of liver blood tests, synthetic failure, severe electrolyte abnormalities (K+ >6.0 mmol/L, Na+ <120 mmol/L), or acute kidney injury with oliguria should be immediately referred to ICU or emergency department for urgent evaluation and treatment. 1, 2

Critical Values Requiring Emergency/ICU Admission:

Serum Potassium >6.0 mmol/L with or without ECG changes 2, 3
Serum Creatinine rise >0.3 mg/dL within 48 hours or >1.5 times baseline 1
Serum Sodium <120 mmol/L or symptomatic hyponatremia 4
Total Bilirubin >5 mg/dL with coagulopathy (INR >1.5) 1
SGOT/SGPT >5 times upper limit of normal with synthetic dysfunction 1
Ionized Calcium <0.9 mmol/L with tetany or seizures 5

ICU Prescription for Critical Abnormalities

Severe Hyperkalemia (K+ >6.0 mmol/L):

Immediate ECG monitoring is mandatory, as hyperkalemia can cause life-threatening cardiac arrhythmias and sudden death. 2, 3

Treatment Protocol:

Calcium Gluconate 10% 10-20 mL IV over 2-5 minutes (DO NOT exceed 200 mg/minute infusion rate) for cardiac membrane stabilization 5
Regular Insulin 10 units IV with 50 mL of 50% Dextrose (or 25g glucose) to shift potassium intracellularly 2, 4
Sodium bicarbonate 50 mEq IV if concurrent metabolic acidosis present 3
Continuous cardiac monitoring throughout treatment 2, 6
Repeat serum potassium every 1-2 hours during acute management 2
Initiate hemodialysis if K+ >6.5 mmol/L or refractory to medical management 7

Critical Pitfall: Always rule out pseudohyperkalemia from hemolysis or poor phlebotomy technique before aggressive treatment—repeat sample with proper technique or obtain arterial sample. 2, 3

Acute Kidney Injury with Electrolyte Derangement:

Monitor serum creatinine, urea, electrolytes (Na+, K+, Ca2+, PO4, Mg2+) every 4-6 hours in ICU setting. 2, 3

Management Algorithm:

Identify prerenal vs. renal vs. postrenal causes through history, examination, urine microscopy, and renal ultrasound 1
Discontinue all nephrotoxic medications (NSAIDs, aminoglycosides, ACE inhibitors/ARBs in acute setting) 3
Fluid resuscitation with isotonic saline if prerenal azotemia suspected (avoid Ringer's Lactate if hyperkalemia present) 4
Strict input-output charting with urine output monitoring 1
Initiate renal replacement therapy if: oliguria (<0.5 mL/kg/hr for >6 hours), severe hyperkalemia (>6.5 mmol/L), severe metabolic acidosis (pH <7.1), or uremic complications 1

For patients on continuous renal replacement therapy, monitor electrolytes every 4-6 hours due to significant electrolyte shifts. 2

Severe Hypocalcemia (Ionized Ca2+ <0.9 mmol/L):

Calcium Gluconate Injection Protocol: 5

Adults: 1000-2000 mg IV bolus (diluted to 10-50 mg/mL concentration) over 10 minutes, DO NOT exceed 200 mg/minute
Repeat every 6 hours if symptomatic or severe
Continuous infusion: 5.4-21.5 mg/kg/hour for persistent hypocalcemia
Monitor serum calcium every 4-6 hours during intermittent infusions, every 1-4 hours during continuous infusion 5
Ensure adequate magnesium levels (hypomagnesemia prevents calcium correction) 2, 6

In renal impairment, initiate at lowest recommended dose and monitor calcium every 4 hours. 5

Severe Liver Dysfunction with Coagulopathy:

Patients with marked liver enzyme elevation (>5x ULN), hyperbilirubinemia, and synthetic failure require urgent hepatology consultation. 1

ICU Management:

Fresh frozen plasma 10-15 mL/kg if INR >1.5 and active bleeding or pre-procedure 1
Vitamin K 10 mg IV for cholestatic jaundice 1
N-acetylcysteine infusion if drug-induced hepatotoxicity suspected 1
Monitor for hepatic encephalopathy with lactulose 30 mL TDS and rifaximin 550 mg BD 1
Avoid hepatotoxic drugs and adjust doses for hepatic impairment 1

Emergency Department Prescription

Moderate Hyperkalemia (K+ 5.5-6.0 mmol/L):

Obtain immediate ECG; if any ECG changes present, treat as severe hyperkalemia. 2, 3

Treatment if asymptomatic with normal ECG:

Calcium resonium (sodium polystyrene sulfonate) 15g PO TDS 8
Furosemide 40-80 mg IV to enhance renal potassium excretion 3
Repeat potassium in 2-4 hours 2
Review all medications causing hyperkalemia (ACE inhibitors, ARBs, spironolactone, NSAIDs, trimethoprim-sulfamethoxazole, beta-blockers) 2, 3

Acute Kidney Injury (Creatinine 1.5-3x baseline):

Perform urgent renal ultrasound to exclude obstructive uropathy. 1

Emergency Management:

IV fluid resuscitation with normal saline 500-1000 mL bolus if hypovolemic 1
Bladder catheterization if urinary retention suspected 1
Hold nephrotoxic drugs 3
Admit for monitoring if creatinine rising or oliguria present 1

Moderate Liver Enzyme Elevation (ALT/AST 2-5x ULN):

Initiate liver aetiology screen in emergency department: 1

Abdominal ultrasound
Hepatitis B surface antigen, Hepatitis C antibody with PCR if positive
Anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody
Serum immunoglobulins
Serum ferritin and transferrin saturation
Alcohol history with AUDIT score 1

If cholestatic pattern (ALP >2x ULN with bilirubin elevation), urgent ultrasound to exclude biliary obstruction. 1

Inpatient Department (IPD) Prescription

Mild-Moderate Renal Dysfunction:

Daily monitoring of serum creatinine, urea, electrolytes until stable, then every 2-3 days. 1

Management:

Maintain euvolemia with balanced crystalloids 1
Adjust drug doses for GFR (use CKD-EPI equation for estimation) 1
Target blood pressure <130/80 mmHg if chronic kidney disease 1
Dietary potassium restriction <2g/day if hyperkalemia 3
Phosphate binders with meals if hyperphosphatemia present 3

Mild Liver Enzyme Elevation (ALT/AST <2x ULN):

Complete liver aetiology screen as per guideline recommendations. 1

For NAFLD (if metabolic syndrome present):

Calculate FIB-4 or NAFLD Fibrosis Score for risk stratification 1
Lifestyle modification: weight loss target 7-10% body weight, exercise 150 min/week 1
Optimize diabetes and lipid control 1
Repeat liver function tests in 3-6 months 1

For alcohol-related liver disease (AUDIT score >19):

Refer to alcohol cessation services 1
Fibroscan/ARFI elastography for fibrosis assessment 1
Refer to hepatology if Fibroscan >16 kPa 1

Electrolyte Abnormalities (Mild):

Hyponatremia (Na+ 125-135 mmol/L):

Assess volume status (hypovolemic vs. euvolemic vs. hypervolemic) 4
Fluid restriction to 1-1.5L/day if SIADH suspected 4
Correct slowly: maximum 8-10 mmol/L in 24 hours to avoid osmotic demyelination syndrome 4
Monitor sodium every 6-12 hours during correction 4

Hyperkalemia (K+ 5.0-5.5 mmol/L):

Dietary potassium restriction 3
Discontinue potassium-sparing agents 3
Calcium resonium 15g PO TDS 8
Monitor potassium every 12-24 hours 2

Outpatient Department (OPD) Prescription

Chronic Kidney Disease Monitoring:

Establish CKD stage using eGFR and initiate appropriate management. 1

Monitoring Schedule:

Stage 1-2 (eGFR >60): Annual creatinine, electrolytes, urine albumin-creatinine ratio 1
Stage 3 (eGFR 30-60): Every 6 months 1
Stage 4 (eGFR 15-30): Every 3 months 1
Stage 5 (eGFR <15): Monthly and nephrology referral for dialysis planning 1

Medications:

ACE inhibitor or ARB if proteinuria present (monitor K+ and creatinine at 1-2 weeks) 1
Sodium bicarbonate 650 mg TDS if metabolic acidosis (HCO3 <22 mmol/L) 1
Erythropoietin-stimulating agents if anemia (Hb <10 g/dL) with iron supplementation 1

Asymptomatic Mild Liver Enzyme Elevation:

Complete initial workup with liver aetiology screen before labeling as "non-specific." 1

If initial screen negative:

Repeat liver function tests in 3 months 1
If persistently abnormal, refer to gastroenterology/hepatology for further evaluation including possible liver biopsy 1
Do not dismiss as insignificant without complete evaluation 1

Isolated Hyperbilirubinemia:

Determine if conjugated (direct) or unconjugated (indirect) hyperbilirubinemia. 1

Unconjugated hyperbilirubinemia (indirect >80% of total):

Gilbert's syndrome most common if mild elevation (<3 mg/dL), fluctuating, and triggered by fasting/illness 1
No specific treatment required for Gilbert's syndrome 1
Rule out hemolysis with CBC, reticulocyte count, LDH, haptoglobin 1

Conjugated hyperbilirubinemia (direct >20% of total):

Requires complete hepatobiliary evaluation with ultrasound and liver aetiology screen 1
Refer to gastroenterology if persistent or progressive 1

Laboratory Monitoring Frequency Summary

Setting	Parameter	Frequency
ICU	K+, Na+, Ca2+, Creatinine	Every 4-6 hours [2,3]
ICU (on CRRT)	All electrolytes	Every 4-6 hours [2]
ICU (Ca2+ infusion)	Ionized calcium	Every 1-4 hours [5]
Emergency	K+ (if hyperkalemic)	Every 2-4 hours [2]
IPD	Creatinine, electrolytes	Daily until stable, then every 2-3 days [1]
OPD (CKD Stage 3)	Creatinine, electrolytes	Every 6 months [1]
OPD (CKD Stage 4)	Creatinine, electrolytes	Every 3 months [1]

Critical Drug Interactions and Contraindications

Do not mix Calcium Gluconate with ceftriaxone—contraindicated in neonates and can cause fatal precipitates in any age group. 5

Avoid Ringer's Lactate in hyperkalemia or alkalosis—lactate metabolizes to bicarbonate and solution contains potassium. 4

Review and discontinue medications causing hyperkalemia: ACE inhibitors, ARBs, spironolactone, amiloride, NSAIDs, trimethoprim-sulfamethoxazole, heparin, calcineurin inhibitors, beta-blockers. 2, 3

Help us tailor your experience